ScanSource Q2 sales and EPS miss analyst estimates

Reuters
Feb 05
<a href="https://laohu8.com/S/SCSC">ScanSource</a> <a href="https://laohu8.com/S/QTWO">Q2</a> sales and EPS miss analyst estimates

Overview

  • Technology distributor's Q2 FY26 sales missed analyst expectations

  • Adjusted EPS for Q2 FY26 missed analyst expectations

  • Company announced leadership changes in board committees

Outlook

  • ScanSource revises FY26 net sales forecast to $3.0 bln-$3.1 bln from $3.1 bln-$3.3 bln

  • Company lowers FY26 adjusted EBITDA forecast to $140 mln-$150 mln from $150 mln-$160 mln

  • ScanSource maintains FY26 free cash flow forecast at least $80 mln

Result Drivers

  • RECURRING REVENUE GROWTH - Recurring revenue increased 15.9% year-over-year, contributing significantly to overall sales growth

  • SEGMENT PERFORMANCE - Specialty Technology Solutions and Intelisys & Advisory segments drove sales growth, with North America leading the increase

  • CASH FLOW STRENGTH - Company reported strong free cash flow, supporting its strategic goals

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Sales

Miss

$766.51 mln

$779.40 mln (3 Analysts)

Q2 Adjusted EPS

Miss

$0.80

$1.01 (4 Analysts)

Q2 Adjusted Net Income

$17.61 mln

Q2 Adjusted EBITDA

$31.19 mln

Q2 Gross Profit

$102.91 mln

Q2 Operating Income

$17.87 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the computer hardware peer group is "buy"

  • Wall Street's median 12-month price target for Scansource Inc is $50.00, about 12.8% above its February 4 closing price of $44.33

  • The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 10 three months ago

Press Release: ID:nBw1psJ9Ka

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10